US 12,523,783 · Application 18/220,557 · Granted Jan 13, 2026
US 12,523,783
Gnss measurement processing with carrier phase residual error model
Estimated expiration
July 22, 2044
17y 322d remaining
Earliest effective filing
Jul 11, 2023
+ 20 years
Jul 11, 2043
PTA +377d
Jul 22, 2044
No TD
—
Final
Jul 22, 2044
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- July 11, 2023
- Earliest effective filing
- July 11, 2023
- Issue date
- January 13, 2026
- PTA
- +377 days
- Base expiry (before PTA)
- July 11, 2043
July 11, 2023 + 20 years = July 11, 2043 + 377 PTA days = July 22, 2044
Continuity chain
No continuity chain; the patent’s own filing date was used.
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 18/220,557 · US 12,523,783
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 12,523,783: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US12523783Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.